CytoMed Therapeutics Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was SGD 4.13 million compared to SGD 3.13 million a year ago. Basic loss per share from continuing operations was SGD 0.39 compared to SGD 0.4 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.067 USD | +2.34% | -2.49% | -57.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-57.81% | 23.86M | |
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.69% | 21.78B | |
-10.60% | 18.09B | |
-41.25% | 16.72B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |
- Stock Market
- Equities
- GDTC Stock
- News CytoMed Therapeutics Limited
- CytoMed Therapeutics Limited Reports Earnings Results for the Full Year Ended December 31, 2023